STRUCTURAL ELEMENTS OF H1-RECEPTORS AND H2-RECEPTORS OF HISTAMINE

被引：2

作者：

GRECHISHKIN, LL

GOLDFARB, VL

GAVROVSKAYA, LK

BROVTSYNA, NB

机构：

来源：

GENERAL PHARMACOLOGY | 1980年 / 11卷 / 01期

关键词：

D O I：

10.1016/0306-3623(80)90009-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：33 / 36

页数：4

共 19 条

[1] NAMING OF SUBSTITUTED HISTAMINES [J].

BLACK, JW ;

GANELLIN, CR .

EXPERIENTIA, 1974, 30 (01) :111-113

[2] DEFINITION AND ANTAGONISM OF HISTAMINE H2-RECEPTORS [J].

BLACK, JW ;

PARSONS, EM ;

DURANT, CJ ;

DUNCAN, WAM ;

GANELLIN, CR .

NATURE, 1972, 236 (5347) :385-&

[3]

Bovet D, 1937, CR SOC BIOL, V124, P547

[4] CHEMICAL DIFFERENTIATION OF HISTAMINE H1-RECEPTOR AND H2-RECEPTOR AGONISTS [J].

DURANT, GJ ;

GANELLIN, CR ;

PARSONS, ME .

JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (09) :905-909

[5] CONFORMATION OF HISTAMINE DERIVATIVES .3. RELATIONSHIP BETWEEN CONFORMATION AND PHARMACOLOGICAL ACTIVITY [J].

GANELLIN, CR .

JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (06) :620-623

[6] TAUTOMER RATIO OF HISTAMINE [J].

GANELLIN, CR .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (10) :787-792

[7] EFFECT OF DERIVATIVES OF 3-(BETA-AMINOETHYL)-1,2,4-TRIAZOLE ON HISTAMINE H1-RECEPTOR AND H2-RECEPTOR [J].

GRECHISHKIN, LL ;

GAVROVSKAYA, LK ;

GOLDFARB, VL .

PHARMACOLOGY, 1977, 15 (06) :512-518

[8]

GRECHISHKIN LL, 1976, PHARMAC TOXIC, V39, P556

[9]

GRECHISHKIN LL, 1979, PHARMAC TOXIC, V42, P197

[10]

GRECHISHKIN LL, 1976, 4TH ALL UN M PHARM L, P52

← 1 2 →